Logotipo do repositório
 

Publicação:
Acute kidney function and morphology following topload administration of recombinant hemoglobin solution

dc.contributor.authorMartucci, Alexandre Fabricio [UNESP]
dc.contributor.authorFerreira Abreu Martucci, Ana Carolina Carvalho [UNESP]
dc.contributor.authorCabrales, Pedro
dc.contributor.authorNascimento, Paulo do [UNESP]
dc.contributor.authorIntaglietta, Marcos
dc.contributor.authorTsai, Amy G.
dc.contributor.authorMachado Castiglia, Yara Marcondes [UNESP]
dc.contributor.institutionUniversidade Estadual Paulista (Unesp)
dc.contributor.institutionUniv Calif San Diego
dc.date.accessioned2018-11-26T17:15:37Z
dc.date.available2018-11-26T17:15:37Z
dc.date.issued2017-02-01
dc.description.abstractThere is a 0.138% incidence of adverse reactions related to blood transfusion. Transfusion-related acute lung injury, immunosuppression, fever, pathogen transmission, and hemolytic transfusion reactions are the most common ones. Synthetic oxygen carriers have been developed to deal with blood shortages and for use in the field where stored blood was not available. They were also designed to be pathogen free, including unknown viruses. In this study, we used Male Golden Syrian Hamsters implemented with a dorsal window chamber to determine how infusion of three different, genetically crosslinked recombinant acellular hemoglobin (rHb) solutions with different oxygen affinities and nitric oxide kinetics affect mean arterial pressure (MAP), heart rate (HR), kidney function, and kidney structure. We found that the administration of all three rHb solutions caused mild hypertension and bradycardia 30minutes after infusion. However, acute changes in glomerular filtration rate (GFR) were not detected, even though histological analysis was performed 72hours after treatment revealed some structural changes. All the rHb solutions resulted in hypertension 30minutes after a 10% topload administration. Regardless of their properties, the presence of acellular Hb causes significant alterations to kidney tissue.en
dc.description.affiliationUniv Estadual Paulista, Dept Anaesthesiol, Botucatu, SP, Brazil
dc.description.affiliationUniv Calif San Diego, Dept Bioengn, La Jolla, CA 92093 USA
dc.description.affiliationUniv Calif San Diego, Dept Bioengn, Microhemodynam Lab, La Jolla, CA 92093 USA
dc.description.affiliationUnespUniv Estadual Paulista, Dept Anaesthesiol, Botucatu, SP, Brazil
dc.description.sponsorshipNIH
dc.description.sponsorshipCoordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES)
dc.description.sponsorshipIdNIH: PO1 HL 110900
dc.description.sponsorshipIdCAPES: 99999.005137/2014-04
dc.format.extent24-30
dc.identifierhttp://dx.doi.org/10.1080/21691401.2016.1241795
dc.identifier.citationArtificial Cells Nanomedicine And Biotechnology. Abingdon: Taylor & Francis Ltd, v. 45, n. 1, p. 24-30, 2017.
dc.identifier.doi10.1080/21691401.2016.1241795
dc.identifier.issn2169-1401
dc.identifier.urihttp://hdl.handle.net/11449/162323
dc.identifier.wosWOS:000391459800004
dc.language.isoeng
dc.publisherTaylor & Francis Ltd
dc.relation.ispartofArtificial Cells Nanomedicine And Biotechnology
dc.rights.accessRightsAcesso restrito
dc.sourceWeb of Science
dc.subjectBlood substitutes
dc.subjectglomerular filtration rate
dc.subjectfluorescein-isothiocyanate sinistrin
dc.subjectacute kidney injury
dc.titleAcute kidney function and morphology following topload administration of recombinant hemoglobin solutionen
dc.typeArtigo
dcterms.licensehttp://journalauthors.tandf.co.uk/permissions/reusingOwnWork.asp
dcterms.rightsHolderTaylor & Francis Ltd
dspace.entity.typePublication
unesp.author.orcid0000-0002-8794-2839[3]
unesp.campusUniversidade Estadual Paulista (UNESP), Faculdade de Medicina, Botucatupt
unesp.departmentAnestesiologia - FMBpt

Arquivos